Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Four-Dimensional Computed Tomography | 4 | 2022 | 145 | 1.390 |
Why?
|
| Hyperparathyroidism, Primary | 2 | 2022 | 155 | 1.280 |
Why?
|
| Parathyroidectomy | 4 | 2021 | 235 | 1.160 |
Why?
|
| Parathyroid Neoplasms | 2 | 2022 | 245 | 0.850 |
Why?
|
| Parathyroid Diseases | 1 | 2020 | 48 | 0.740 |
Why?
|
| Tomography, X-Ray Computed | 19 | 2023 | 20086 | 0.710 |
Why?
|
| Hyperparathyroidism | 3 | 2021 | 339 | 0.620 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 2 | 2017 | 197 | 0.610 |
Why?
|
| Salivary Glands | 1 | 2018 | 228 | 0.600 |
Why?
|
| Head and Neck Neoplasms | 6 | 2023 | 2712 | 0.580 |
Why?
|
| Mouth Diseases | 1 | 2018 | 239 | 0.560 |
Why?
|
| Mouth | 1 | 2018 | 373 | 0.550 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2022 | 35342 | 0.480 |
Why?
|
| Preoperative Care | 3 | 2018 | 2245 | 0.480 |
Why?
|
| Ear Canal | 1 | 2015 | 146 | 0.480 |
Why?
|
| Otologic Surgical Procedures | 1 | 2015 | 145 | 0.450 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1107 | 0.450 |
Why?
|
| Skull Base | 1 | 2016 | 299 | 0.430 |
Why?
|
| Information Dissemination | 1 | 2020 | 1100 | 0.420 |
Why?
|
| Spinal Diseases | 1 | 2017 | 538 | 0.420 |
Why?
|
| Skull Base Neoplasms | 1 | 2016 | 284 | 0.410 |
Why?
|
| Adenoma | 1 | 2022 | 2168 | 0.390 |
Why?
|
| Lymph Nodes | 4 | 2023 | 3465 | 0.370 |
Why?
|
| Radiology | 2 | 2021 | 2090 | 0.360 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.360 |
Why?
|
| Trochlear Nerve | 2 | 2021 | 25 | 0.360 |
Why?
|
| Meglumine | 1 | 2009 | 149 | 0.340 |
Why?
|
| Parathyroid Glands | 2 | 2022 | 509 | 0.320 |
Why?
|
| Neck | 5 | 2022 | 693 | 0.320 |
Why?
|
| Brain Diseases | 1 | 2017 | 1554 | 0.310 |
Why?
|
| Students, Medical | 1 | 2020 | 1858 | 0.300 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2023 | 475 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2017 | 4029 | 0.300 |
Why?
|
| Ultrasonography | 2 | 2018 | 5978 | 0.270 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 665 | 0.270 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 1009 | 0.260 |
Why?
|
| Internship and Residency | 2 | 2021 | 5774 | 0.230 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 802 | 0.230 |
Why?
|
| Cerebral Angiography | 4 | 2013 | 1285 | 0.230 |
Why?
|
| Dyskinesias | 1 | 2023 | 78 | 0.230 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3507 | 0.220 |
Why?
|
| Osteitis Fibrosa Cystica | 1 | 2021 | 11 | 0.210 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 2 | 2013 | 105 | 0.200 |
Why?
|
| Confusion | 1 | 2023 | 275 | 0.200 |
Why?
|
| Papillomavirus Infections | 2 | 2023 | 1585 | 0.190 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2021 | 129 | 0.190 |
Why?
|
| Amyloidogenic Proteins | 1 | 2021 | 151 | 0.180 |
Why?
|
| Anemia, Aplastic | 1 | 2021 | 226 | 0.170 |
Why?
|
| Emergencies | 3 | 2022 | 1164 | 0.170 |
Why?
|
| Salivary Gland Diseases | 1 | 2018 | 37 | 0.170 |
Why?
|
| Hypercalcemia | 1 | 2021 | 405 | 0.170 |
Why?
|
| Face | 2 | 2021 | 993 | 0.150 |
Why?
|
| Neuroradiography | 1 | 2017 | 70 | 0.150 |
Why?
|
| Parotid Gland | 1 | 2018 | 168 | 0.150 |
Why?
|
| Diagnosis, Differential | 8 | 2021 | 12958 | 0.150 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2016 | 44 | 0.140 |
Why?
|
| Exanthema | 1 | 2021 | 488 | 0.140 |
Why?
|
| Contrast Media | 5 | 2020 | 5295 | 0.140 |
Why?
|
| Manikins | 1 | 2017 | 238 | 0.140 |
Why?
|
| Neurilemmoma | 1 | 2021 | 547 | 0.130 |
Why?
|
| Burkitt Lymphoma | 1 | 2018 | 328 | 0.130 |
Why?
|
| Head | 2 | 2021 | 878 | 0.130 |
Why?
|
| Syphilis | 1 | 2018 | 226 | 0.130 |
Why?
|
| Neck Dissection | 1 | 2016 | 196 | 0.130 |
Why?
|
| Humans | 41 | 2023 | 742088 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 168 | 0.130 |
Why?
|
| Scalp | 2 | 2021 | 380 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2017 | 1183 | 0.120 |
Why?
|
| Temporal Bone | 2 | 2015 | 661 | 0.110 |
Why?
|
| Labyrinth Diseases | 1 | 2015 | 150 | 0.110 |
Why?
|
| Vision Disorders | 1 | 2021 | 1057 | 0.110 |
Why?
|
| Semicircular Canals | 1 | 2015 | 198 | 0.110 |
Why?
|
| Ear Diseases | 1 | 2015 | 169 | 0.110 |
Why?
|
| Professional Competence | 1 | 2006 | 448 | 0.110 |
Why?
|
| Ear, Middle | 1 | 2015 | 332 | 0.110 |
Why?
|
| Lymphatic Metastasis | 2 | 2017 | 2906 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2009 | 7276 | 0.110 |
Why?
|
| Hematoma, Subdural | 1 | 2013 | 126 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2374 | 0.100 |
Why?
|
| Thyroidectomy | 1 | 2016 | 877 | 0.100 |
Why?
|
| Cerebral Hemorrhage | 2 | 2013 | 2643 | 0.100 |
Why?
|
| Bone Marrow | 1 | 2021 | 2941 | 0.090 |
Why?
|
| Myosins | 2 | 2002 | 409 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2013 | 5310 | 0.090 |
Why?
|
| Spine | 1 | 2017 | 1143 | 0.090 |
Why?
|
| Thyroid Gland | 1 | 2016 | 1172 | 0.090 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2010 | 103 | 0.080 |
Why?
|
| Head Injuries, Closed | 1 | 2010 | 136 | 0.080 |
Why?
|
| Phlebography | 1 | 2010 | 333 | 0.080 |
Why?
|
| Skull Fractures | 1 | 2010 | 195 | 0.080 |
Why?
|
| Male | 22 | 2021 | 349538 | 0.080 |
Why?
|
| Aged, 80 and over | 11 | 2017 | 57683 | 0.080 |
Why?
|
| Neck Injuries | 1 | 2009 | 152 | 0.080 |
Why?
|
| Middle Aged | 19 | 2021 | 213127 | 0.080 |
Why?
|
| Emergency Medicine | 1 | 2017 | 1205 | 0.080 |
Why?
|
| Retrospective Studies | 12 | 2023 | 77098 | 0.080 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 481 | 0.080 |
Why?
|
| Neurosurgical Procedures | 2 | 2012 | 2002 | 0.080 |
Why?
|
| Meningioma | 1 | 2016 | 1209 | 0.080 |
Why?
|
| Young Adult | 7 | 2021 | 56350 | 0.080 |
Why?
|
| Biopsy | 4 | 2021 | 6756 | 0.070 |
Why?
|
| Meningeal Neoplasms | 1 | 2016 | 1241 | 0.070 |
Why?
|
| Female | 20 | 2023 | 379592 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2023 | 11001 | 0.070 |
Why?
|
| Health Personnel | 2 | 2017 | 3210 | 0.070 |
Why?
|
| Thyroid Nodule | 1 | 2013 | 750 | 0.070 |
Why?
|
| Aged | 14 | 2023 | 162944 | 0.070 |
Why?
|
| Proteins | 1 | 2021 | 6096 | 0.070 |
Why?
|
| Craniocerebral Trauma | 1 | 2009 | 482 | 0.060 |
Why?
|
| Liver | 1 | 2021 | 7470 | 0.060 |
Why?
|
| Heart Transplantation | 3 | 2002 | 3119 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 1617 | 0.060 |
Why?
|
| Adult | 13 | 2017 | 213712 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2274 | 0.060 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 794 | 0.060 |
Why?
|
| Eye Pain | 1 | 2022 | 47 | 0.050 |
Why?
|
| Cardiac Myosins | 1 | 2002 | 117 | 0.050 |
Why?
|
| Bone Marrow Examination | 1 | 2021 | 157 | 0.050 |
Why?
|
| Jaw | 1 | 2021 | 96 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 8925 | 0.050 |
Why?
|
| Cytochromes | 1 | 2021 | 19 | 0.050 |
Why?
|
| Facial Pain | 1 | 2022 | 124 | 0.050 |
Why?
|
| Brain | 3 | 2017 | 26343 | 0.050 |
Why?
|
| Sickle Cell Trait | 1 | 2021 | 81 | 0.050 |
Why?
|
| Epistaxis | 1 | 2021 | 111 | 0.050 |
Why?
|
| Oropharynx | 1 | 2021 | 127 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2006 | 6669 | 0.050 |
Why?
|
| Purpura | 1 | 2021 | 122 | 0.050 |
Why?
|
| Adolescent | 8 | 2021 | 85649 | 0.050 |
Why?
|
| Licensure | 1 | 2021 | 124 | 0.050 |
Why?
|
| Graft Rejection | 3 | 2002 | 4393 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2021 | 293 | 0.050 |
Why?
|
| Telemedicine | 1 | 2017 | 2853 | 0.050 |
Why?
|
| HIV-1 | 1 | 2018 | 6934 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2021 | 411 | 0.050 |
Why?
|
| Electron Transport | 1 | 2021 | 211 | 0.050 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 2021 | 115 | 0.040 |
Why?
|
| Pharyngitis | 1 | 2021 | 215 | 0.040 |
Why?
|
| Blepharoptosis | 1 | 2021 | 144 | 0.040 |
Why?
|
| Electrons | 1 | 2021 | 268 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2021 | 528 | 0.040 |
Why?
|
| Comorbidity | 2 | 2013 | 10372 | 0.040 |
Why?
|
| Myocardium | 2 | 2002 | 4775 | 0.040 |
Why?
|
| Observer Variation | 2 | 2013 | 2593 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 413 | 0.040 |
Why?
|
| Uncertainty | 1 | 2023 | 725 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 854 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2012 | 3456 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 417 | 0.040 |
Why?
|
| Massachusetts | 1 | 2009 | 8662 | 0.040 |
Why?
|
| Tyrosine | 1 | 2021 | 1460 | 0.030 |
Why?
|
| Prevalence | 2 | 2010 | 15194 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 19862 | 0.030 |
Why?
|
| Geniculate Ganglion | 1 | 2015 | 8 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15530 | 0.030 |
Why?
|
| Protons | 1 | 2021 | 1126 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2187 | 0.030 |
Why?
|
| Brain Neoplasms | 2 | 2012 | 8829 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2021 | 878 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2021 | 1206 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1612 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 5662 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1618 | 0.030 |
Why?
|
| Algorithms | 2 | 2023 | 13853 | 0.030 |
Why?
|
| Graft Survival | 1 | 2002 | 3733 | 0.030 |
Why?
|
| HIV Infections | 1 | 2018 | 16678 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 1811 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2012 | 524 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14720 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2011 | 570 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1650 | 0.020 |
Why?
|
| Transplantation, Homologous | 3 | 2002 | 4771 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2006 | 2290 | 0.020 |
Why?
|
| Brain Stem | 1 | 2014 | 844 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2010 | 204 | 0.020 |
Why?
|
| Hematoma | 1 | 2013 | 755 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 23320 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2002 | 10163 | 0.020 |
Why?
|
| Craniotomy | 1 | 2012 | 729 | 0.020 |
Why?
|
| Acute Disease | 2 | 2013 | 7141 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1849 | 0.020 |
Why?
|
| Logistic Models | 2 | 2013 | 13403 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 72145 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15056 | 0.020 |
Why?
|
| Causality | 1 | 2013 | 1265 | 0.020 |
Why?
|
| Infant | 3 | 2014 | 35070 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 1653 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2018 | 2301 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2014 | 40955 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8621 | 0.020 |
Why?
|
| Models, Biological | 1 | 2021 | 9581 | 0.020 |
Why?
|
| Prognosis | 2 | 2013 | 29010 | 0.010 |
Why?
|
| Autoimmunity | 2 | 2002 | 1348 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3510 | 0.010 |
Why?
|
| Child | 4 | 2014 | 77478 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2002 | 6382 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 2038 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 2001 | 248 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2002 | 273 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9846 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2002 | 526 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2736 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9305 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12242 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2002 | 1146 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12773 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11363 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2002 | 1402 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2002 | 2003 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2002 | 1056 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2002 | 1049 | 0.010 |
Why?
|
| Chronic Disease | 2 | 2002 | 9144 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 1366 | 0.010 |
Why?
|
| Epitopes | 1 | 2002 | 2569 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 4564 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 20928 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2002 | 21821 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15244 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 9185 | 0.010 |
Why?
|
| United States | 1 | 2021 | 69693 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2001 | 3199 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 5519 | 0.010 |
Why?
|
| Erythema Multiforme | 1 | 1951 | 31 | 0.010 |
Why?
|
| Mice | 3 | 2002 | 81045 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 53187 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 40450 | 0.010 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 1951 | 277 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2013 | 62966 | 0.000 |
Why?
|
| Animals | 3 | 2002 | 168561 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 9274 | 0.000 |
Why?
|
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(67)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_